Create Alert
Watchlist

Sharon Bio-Medicine Ltd.

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
NA
Prev. Close
NA
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Sharon Bio-Medicine

Sharon Bio-Medicine Limited is an India-based pharmaceutical company. The Company is engaged in providing a range of pharmaceutical products and services, including animal toxicology and manufacturing of finished dosages. The Company's products include active pharma ingredients (APIs) and intermediates, and formulations. Its APIs and intermediates include Ketoconazole, Miconazole Nitrate, Sertaconazole Nitrate, Trimetazidine Di HCl, Nifedipine, Atomoxetine HCl, Trazodone HCl, Memantine HCI, Eperisone HCl, Glimepiride, Mosapride Citrate Dihydrate and Aripiprazole. Its formulation includes Aripiprazole tablets, Atorvastatin tablets, Azithromycin tablets, Betahistine tablets, Carbimazole tablets, Celecoxib capsules, Clopidogrel tablets, Carbocisteine capsules, Enalapril Maleate tablets, Donepezil tablets, Ezetimibe tablets and Famciclovir tablets. Its manufacturing facility is located at Navi Mumbai.;
Parent OrganisationSharon Bio-medicine Limited
Managing DirectorNA
Founded1989

Shareholding Pattern

Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Retail And Others
99.98%
Other Domestic Institutions
0.02%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
99.95
JB Chemicals & Pharmaceuticals
NA
(0.00%)
38.11
Emcure Pharmaceuticals
NA
(0.00%)
34.13
Wockhardt
NA
(0.00%)
-192.50